Literature DB >> 194484

Effect of dichloromethane diphosphonate on calcium homeostatic mechanisms in pregnant cows.

J T Yarrington, C C Capen, H E Black, R Re, L A Nagode, W B Geho.   

Abstract

The administration of 4 mg/kg/day of dichloromethane diphosphonate (Cl2MDP) subcutaneously to pregnant cows fed a low-calcium diet significantly reduced bone resorption as indicated by microradiographic evaluation of endosteal surfaces of cross sections of ribs. Plasma parathyroid hormone levels were similar between Cl2MDP-treated and control cows prepartum, during EDTA infusions, and near parturition. Ultrastructurally, chief cells of the parathyroid glands of both groups of cows were in the active stage of the secretory cycle. The chronically stimulated chief cell from cows administered Cl2MDP had a large cytoplasmic area containing many lipofuscin granules and lysosomal bodies and a few secretory granules near the large Golgi apparatus or aligned along the plasma membrane. Uptake of calcium 45 by the duodenal mucosa incubated in vitro was greater in Cl2MDP-treated cows compared to control cows. The administration of Cl2MDP significantly reduced rapidly mobilization calcium reserves. Following an intravenous EDTA infusion and the spontaneous calcium drain associated with parturition and the beginning of lactation, Cl2MDP-treated cows developed severe hypocalcemia. The rapid mobilization of calcium reserves in cows administered Cl2MDP prepartum was impaired mainly because of diminished resorption of bone despite adequate parathyroid hormone secretion in response to severe postpartal or EDTA-induced hypocalcemia.

Entities:  

Mesh:

Substances:

Year:  1977        PMID: 194484      PMCID: PMC2032129     

Source DB:  PubMed          Journal:  Am J Pathol        ISSN: 0002-9440            Impact factor:   4.307


  24 in total

1.  Effect of fasting and parathyroid hormone injection on plasma 45Ca concentrations in rats.

Authors:  R V Talmage
Journal:  Calcif Tissue Res       Date:  1975

2.  Modifications of a specific assay for hydroxyproline in urine.

Authors:  K I Kivirikko; O Laitinen; D J Prockop
Journal:  Anal Biochem       Date:  1967-05       Impact factor: 3.365

3.  The hyperphosphatemic effect of disodium ethane-1-hydroxy-1,1-diphosphonate (EHDP TM ): renal handling of phosphorus and the renal response to parathyroid hormone.

Authors:  R R Recker; G S Hassing; J R Lau; P D Saville
Journal:  J Lab Clin Med       Date:  1973-02

4.  Parathyroid hormone-sensitive adenyl cyclase in isolated renal tubules.

Authors:  G L Melson; L R Chase; G D Aurbach
Journal:  Endocrinology       Date:  1970-03       Impact factor: 4.736

5.  Vitamin D-dependent calcium-binding protein. Purification and some properties.

Authors:  R H Wasserman; R A Corradino; A N Taylor
Journal:  J Biol Chem       Date:  1968-07-25       Impact factor: 5.157

6.  The influence of pyrophosphate, condensed phosphates, phosphonates and other phosphate compounds on the dissolution of hydroxyapatite in vitro and on bone resorption induced by parathyroid hormone in tissue culture and in thyroparathyroidectomised rats.

Authors:  R G Russell; R C Mühlbauer; S Bisaz; D A Williams; H Fleisch
Journal:  Calcif Tissue Res       Date:  1970

7.  The inhibition of calcium hydroxypatite crystal growth by polyphosphonates and polyphosphates.

Authors:  M D Francis
Journal:  Calcif Tissue Res       Date:  1969

8.  An improved method for the biological assay of thyrocalcitonin.

Authors:  C W Cooper; P F Hirsch; S U Toverud; P L Munson
Journal:  Endocrinology       Date:  1967-09       Impact factor: 4.736

9.  Radioimmunoassay for the measurement of adenosine 3',5'-cyclic phosphate.

Authors:  A L Steiner; D M Kipnis; R Utiger; C Parker
Journal:  Proc Natl Acad Sci U S A       Date:  1969-09       Impact factor: 11.205

10.  Diphosphonates inhibit hydroxyapatite dissolution in vitro and bone resorption in tissue culture and in vivo.

Authors:  H Fleisch; R G Russell; M D Francis
Journal:  Science       Date:  1969-09-19       Impact factor: 47.728

View more
  1 in total

Review 1.  Clodronate. A review of its pharmacological properties and therapeutic efficacy in resorptive bone disease.

Authors:  G L Plosker; K L Goa
Journal:  Drugs       Date:  1994-06       Impact factor: 9.546

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.